The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome
Open accessAbstract
Identifying new indications for existing drugs (drug repositioning) is an efficient way of maximizing their potential. Adverse drug reaction (ADR) is one of the leading causes of death among hospitalized patients. As both new indications and ADRs are caused by unexpected chemical-protein interactions on off-targets, it is reasonable to predict these interactions by mining the chemical-protein interactome (CPI). Making such predictions has recently been facilitated by a web server named DRAR-CPI. This server has a representative collection of drug molecules and targetable human proteins built up from our work in drug repositioning and ADR. When a user submits a molecule, the server will give the positive or negative association scores between the user's molecule and our library drugs based on their interaction profiles towards the targets. Users can thus predict the indications or ADRs of their molecule based on the association scores towards our library drugs. We have matched our predictions of drug-drug associations with those predicted via gene-expression profiles, achieving a matching rate as high as 74%. We have also successfully predicted the connections between anti-psychotics and anti-infectives, indicating the underlying relevance of anti-psychotics in the potential treatment of infections, vice versa. This server is freely available at http://cpi.bio-x.cn/drar/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is noteworthy that all ML methods showed relatively small differences in predictive accuracy and the advantage of the DNN was not readily apparent.”
From QSAR without borders (2020) · cites this paper as [114]
In the citing paper
“The performance of several ML methods was evaluated, and again kNN generated the best results, while SEA showed the lowest predictivity.”
From QSAR without borders (2020) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,896
Integration of biological networks and gene expression data using Cytoscape
Cline, M. S., Smoot, M., Cerami, E., Kuchinsky, A., Landys, N., Workman, C., Christmas, R., Avila-Campilo, I., Creech, M., Gross, B., et al. (2007) · Nature Protocols · doi:10.1038/nprot.2007.324 · Cited by 2,507
MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126
Self-citationPredicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases
Ewing, T. J. A., Makino, S., Skillman, A. G., & Kuntz, I. D. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1011115820450 · Cited by 1,188
(1991) · PubMed · Cited by 1,101
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 208
Wang, K., Wan, M., Wang, R., & Weng, Z. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.4541 · Cited by 23
Self-citationARWAR: A network approach for predicting Adverse Drug Reactions
Rahmani, H., Weiß, G., Méndez‐Lucio, O., & Bender, A. (2015) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2015.11.005 · Cited by 23
Systems Pharmacology: A Unified Framework for Prediction of Drug-Target Interactions
Le, D., & Le, L. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160418121534 · Cited by 20
Pereira, A. S. P., Bester, M. J., & Apostolides, Z. (2017) · Molecular Diversity · doi:10.1007/s11030-017-9769-0 · Cited by 20
Wang, K., Sun, J., Zhou, S., Wan, C., Qin, S., Li, C., He, L., & Yang, L. (2013) · PLoS Computational Biology · doi:10.1371/annotation/958d4c23-4f1e-4579-b6ef-8ae1f828b1dd · Cited by 20
Self-citationA pathway profile-based method for drug repositioning
Ye, H., Yang, L., Cao, Z., Tang, K., & Li, Y. (2012) · Chinese Science Bulletin · doi:10.1007/s11434-012-4982-9 · Cited by 19
Self-citationZhang, W., Shao, W., Dong, Z., Zhang, S., Liu, C., & Chen, S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1644-8 · Cited by 19
Identification of a Potential Target of Capsaicin by Computational Target Fishing
Ye, X.-Y., Ling, Q., & Shao-jun, C. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/983951 · Cited by 19
Chávez‐Fumagalli, M. Á., Schneider, M. S., Lage, D. P., Tavares, G. D. S. V., Mendonça, D. V. C., Santos, T. T. D. O., de Pádua, R. M., Machado‐de‐Ávila, R. A., Leite, J. P. V., & Coelho, E. A. F. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/6813467 · Cited by 18
Bu, D., Su, Z., Zou, J., Meng, M., & Wang, C. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109234 · Cited by 18
Li, W., Mikailov, M., & Chen, W. (2023) · IEEE Transactions on Artificial Intelligence · doi:10.1109/tai.2023.3246032 · Cited by 17
Self-citationZhou, S., Su, J., Chang, C., Xiang, Q., Zhou, Z.-W., Luo, R., Yang, L., He, Z., Yang, H., Li, J., et al. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s73476 · Cited by 17
Self-citationIvanov, S. M., Lagunin, A. A., Pogodin, P. V., Filimonov, D. A., & Poroikov, V. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500147d · Cited by 17
TNK2 as a key drug target for the treatment of metastatic colorectal cancer
Qi, L., & Ding, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.07.124 · Cited by 17
In silico drug repositioning using deep learning and comprehensive similarity measures
Yi, H.-C., You, Z., Wang, L., Su, X., Zhou, X., & Jiang, T.-H. (2021) · BMC Bioinformatics · doi:10.1186/s12859-020-03882-y · Cited by 16
Li, L., Li, S., Jiang, J., Liu, C., & Ji, L. (2021) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2021.05.001 · Cited by 16
Iyer, P., Bolla, J., Kumar, V., Gill, M. S., & Sobhia, M. E. (2015) · Molecular Diversity · doi:10.1007/s11030-015-9578-2 · Cited by 16
Drug Repurposing: Insights into Current Advances and Future Applications
Bhatia, T., & Sharma, S. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673266470231023110841 · Cited by 16
Lin, H., Wang, X., Wang, L., Dong, H., Huang, P., Cai, Q., Mo, Y., Huang, F., & Jiang, Z. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/7342635 · Cited by 15
Vincristine attenuates cardiac fibrosis through the inhibition of NLRP3 inflammasome activation
Ge, C., Yang, C. M., Fan, Y., & He, Y. (2021) · Clinical Science · doi:10.1042/cs20210189 · Cited by 14
Molineris, I., Ala, U., Provero, P., & Cunto, F. D. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-288 · Cited by 15
Gómez-Verján, J. C., Rivero-Segura, N. A., Estrella-Parra, E. A., Rincón-Heredia, R., Madariaga‐Mazón, A., Flores‐Soto, E., González-Meljem, J. M., Cerbón, M. A., & Reyes‐Chilpa, R. (2018) · Planta Medica · doi:10.1055/a-0660-0236 · Cited by 14
In Silico Databases and Tools for Drug Repurposing
Serçinoğlu, O., & Özbek, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00024-9 · Cited by 14
Emon, M. A., Domingo‐Fernándéz, D., Hoyt, C. T., & Hofmann‐Apitius, M. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03568-5 · Cited by 12
Faraone, S. V., & Zhang‐James, Y. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32155 · Cited by 13
Drug repositioning beyond the low-hanging fruits
Duran‐Frigola, M., Mateo, L., & Aloy, P. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.04.010 · Cited by 11
Kiani, N. A., Shang, M.-M., Zenil, H., & Tegner, J. N. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7899-1_25 · Cited by 12
Melge, A. R., Manzoor, K., Nair, S. V., & Mohan, C. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00019-5 · Cited by 12
A study on improving drug–drug interactions prediction using convolutional neural networks
Kumari, D., Agrawal, D., Nema, A., Raj, N., Panda, S., Christopher, J. J., Singh, J. K., & Behera, S. (2024) · Applied Soft Computing · doi:10.1016/j.asoc.2024.112242 · Cited by 11
Mukherjee, D., Ahmad, R., & Nayeem, S. M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.069 · Cited by 11
Huang, J., Liang, Y., Tian, W., Ma, J., Huang, L., Ben-jie, L., Chen, R., & Li, D. (2020) · Molecules · doi:10.3390/molecules25173919 · Cited by 11
Application of Network Pharmacology Based on Artificial Intelligence Algorithms in Drug Development
Zhou, W., Li, X., Han, L., & Fan, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-0753-0_2 · Cited by 10
Yang, W.-L. R., Lee, Y.-E., Chen, M., Chao, K., & Huang, C. F. (2012) · Gene · doi:10.1016/j.gene.2012.11.030 · Cited by 10
Overview of Drug Polypharmacology and Multitargeted Molecular Design
Chaudhari, R., Tan, Z., & Zhang, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12323-6 · Cited by 11
Kadioglu, O., & Efferth, T. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0081-x · Cited by 10
Lu, M., Wang, P., Ge, Y., Dworkin, L. D., Brem, A. S., Liu, Z., & Gong, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-29483-7 · Cited by 10
Bioinformatics Perspective of Drug Repurposing
Patel, B., Gelat, B., Soni, M. N., Rathaur, P., & Johar, K. (2023) · Current Bioinformatics · doi:10.2174/0115748936264692230921071504 · Cited by 9
The inhibition of colorectal cancer growth by the natural product macrocarpal I
Qi, L., Zhang, Y., Zhang, W., Wang, Y., Han, Y., & Ding, Y. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.10.317 · Cited by 9
Ban, F., Hu, L., Zhou, X., Zhao, Y., Mo, H., Li, H., & Zhou, W. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2392 · Cited by 8
Network medicine and systems pharmacology approaches to predicting adverse drug effects
Funari, A., Fiscon, G., & Paci, P. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17330 · Cited by 9
Wang, P., Yang, J.-Q., Xu, D., Zhang, S., Lu, S., & Ji, Y. I. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01442-1 · Cited by 9
A new method to identify repositioned drugs for prostate cancer
Wu, Z., Wang, Y., & Chen, L. (2012) · IEEE International Conference on Systems Biology · doi:10.1109/isb.2012.6314150 · Cited by 9
Bellera, C. L., Sbaraglini, M. L., Alberca, L. N., Alice, J. I., & Talevi, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00021-3 · Cited by 9
Song, S., Liu, X., Ji, Q., Sun, D., Xiu, L., Xu, J., & Yue, X. (2022) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2022.02.006 · Cited by 9
Castillo-Arellano, J. I., Gómez-Verján, J. C., Rojano-Vilchis, N. A., Cruz, M. M., Jiménez‐Estrada, M., López-Valdés, H. E., Martínez‐Coria, H., Juárez, R. G., González‐Espinosa, C., Reyes‐Chilpa, R., et al. (2018) · Molecules · doi:10.3390/molecules23123367 · Cited by 9
Drug repositioning framework by incorporating functional information
Wu, Z., Wang, Y., & Chen, L. (2013) · IET Systems Biology · doi:10.1049/iet-syb.2012.0064 · Cited by 9
Xuan, P., Li, P., Cui, H., Wang, M., Nakaguchi, T., & Zhang, T. (2023) · Molecules · doi:10.3390/molecules28186544 · Cited by 8
Cavalla, D., Oerton, E., & Bender, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12283-8 · Cited by 8
Modeling Analysis of Potential Target of Dolastatin 16 by Computational Virtual Screening
Liang, T.-T., Zhao, Q., He, S., Mu, F., Deng, W., & Han, B. (2018) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c17-00966 · Cited by 9
Qi, L., Zhang, Y., Song, F., Han, Y., & Ding, Y. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104625 · Cited by 8
Approaches for network based drug discovery
Jayachandran, P., Ilango, S., Paital, B., Bhanja, S., & Nirmaladevi, R. (2021) · Frontiers in Bioscience-Scholar · doi:10.52586/s551 · Cited by 7
Mei, H., Feng, G., Zhu, J., Lin, S. M., Qiu, Y., Wang, Y., & Xia, T. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_33 · Cited by 7
Xuan, P., Xu, K., Cui, H., Nakaguchi, T., & Zhang, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1257842 · Cited by 6
Machine Learning in Drug Design
Engkvist, O., Mervin, L., Chen, H., & Ran, T. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781788018982-00231 · Cited by 6
Zhao, Q., Li, X., Luo, L., Qian, Y., Liu, Y., & Wu, H.-T. (2018) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c18-00634 · Cited by 6
Evolving Drug Design Methodology: from QSAR to AIDDPreprint
Xu, J. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-9fwmg · Cited by 6
Progress in Natural Products Target Discovery Technology
Pan, Q., Yuan, X., Jin, J., Luan, X., Luo, C., Chen, H., Zhang, W., & Zhang, H. (2026) · MedComm · doi:10.1002/mco2.70777 · Cited by 5
Chen, S.-J., Bi, Y.-H., & Zhang, L.-H. (2021) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001229 · Cited by 5
DrugPathSeeker: Interactive UI for exploring drug-ADR relation via pathways
Verma, J., Luo, H., Hu, J., & Zhang, P. (2017) · IEEE Pacific Visualization Symposium · doi:10.1109/pacificvis.2017.8031602 · Cited by 5
Self-citationSystematic evaluation of the mechanisms of zoledronic acid based on network pharmacology
Liang, X., Li, R., Xu, B., Luo, D., Liu, G.-B., Peng, J., & Li, G. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.107097 · Cited by 5
New opportunity for Chinese pharmaceutical R & D: systematic drug repurposing based on big data
Wang, K., Zhang, Y., Shi, L. M., He, L., & Yang, L. (2014) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/972013-731 · Cited by 5
Self-citationHe, M., Cao, D., Liang, Y., Li, Y.-P., Liu, P., Xu, Q., & Huang, R. (2013) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2013.07.010 · Cited by 5
Bai, H., Lu, S., Zhang, T., Cui, H., Nakaguchi, T., & Xuan, P. (2024) · iScience · doi:10.1016/j.isci.2024.109571 · Cited by 4
Chen, H., Wang, X., Jin, H. Y., Liu, R., & Hou, T. (2016) · SpringerPlus · doi:10.1186/s40064-016-3385-9 · Cited by 4
Networks and Pathways in Systems Pharmacology
Bezerianos, A., Dragomir, A., & Balomenos, P. (2017) · SpringerBriefs in computer science · doi:10.1007/978-3-319-53868-6_2 · Cited by 4
Repurpose Analysis Expanding Biomedical Benefits by Omics Data Integration
Zeng, T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11387-x · Cited by 4
Web-based Tools for Drug Repurposing: Successful Examples of Collaborative Research
Vanhaelen, Q. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200128111925 · Cited by 4
Chemical biology databases: from aggregation, curation to representation
Audouze, K., & Taboureau, O. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.03.003 · Cited by 4
Zhao, Q., Zheng, B., Feng, P., & Li, X. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6694698 · Cited by 4
Computer-aided drug design: An overview
Geronikaki, A. A., Dubey, G., Petrou, A., & Kirubakaran, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18638-7.00024-4 · Cited by 4
Scaling modeling and simulation on high-performance computing clusters
Mikailov, M., Qiu, J., Luo, F.-J., Whitney, S., & Petrick, N. (2019) · SIMULATION · doi:10.1177/0037549719878249 · Cited by 4
Self-citationHu, R., Tian, X., Li, B., Luo, R., Zhang, B., & Zhao, J. (2019) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s230751 · Cited by 4
Li, S., Zhao, H., & Bao, L. (2019) · Letters in Drug Design & Discovery · doi:10.2174/1570180816666190516105906 · Cited by 4
Tang, Y., Gao, S., Luo, D., Jiang, X., Zhao, X., Hu, W., Zhang, Y., Xiao, Z., Han, L., & Zhou, W. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107710 · Cited by 3
Polypharmacology: New Paradigms in Drug Development
Sahrawat, T. R., & Sobti, R. C. (2022) · Springer eBooks · doi:10.1007/978-981-16-9232-1_2 · Cited by 3
Polypharmacology in Clinical Applications: Anti-infection Polypharmacology
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_10 · Cited by 3
Zhu, L., Wang, Y., Huang, X., Liu, X., Ye, B., He, Y., Yu, H., Lv, W., Wang, L., & Hu, J. (2024) · Cancer Medicine · doi:10.1002/cam4.6942 · Cited by 3
In Silico Drug Repurposing for MDR Bacteria: Opportunities and Challenges
Gautam, P., Pal, M. K., & Chaudhry, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00026-2 · Cited by 3
Reinaldo, A., Kusuma, W. A., Rahmawan, H., & Herdiyeni, Y. (2020) · International Conference on Computer Science and Its Application in Agriculture (ICOSICA) · doi:10.1109/icosica49951.2020.9243216 · Cited by 3
Wang, T., Yi, H.-C., You, Z., Li, L.-P., Wang, Y.-B., Hu, L., & Wong, L. (2019) · Lecture notes in computer science · doi:10.1007/978-3-030-26969-2_33 · Cited by 3
Fexofenadine Overcomes Osimertinib Resistance by Inhibiting c‐Met in Non‐Small Cell Lung Cancer
To, K. K. W., Leung, K., & Cho, W. C. S. (2025) · MedComm – Oncology · doi:10.1002/mog2.70019 · Cited by 2
Application of In Silico Drug Repurposing in Infectious Diseases
Kumar, P., & Ghosh, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00015-8 · Cited by 2
Emerging Machine Learning Techniques in Predicting Adverse Drug Reactions
Zhong, Y., Wang, S., Li, G., Ji, Y., Weng, Z., & Luo, H. (2023) · Computational methods in engineering & the sciences · doi:10.1007/978-3-031-20730-3_3 · Cited by 2
Self-citationBacktranslating clinical knowledge for use in cheminformatics—What is the potential?
Scheiber, J. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.04.054 · Cited by 2
丁, 彦., & 齐, 鲁. (2013) · Scientia Sinica Vitae · doi:10.1360/zc2013-43-11-939 · Cited by 2
Jiang, P., Liang, Y., Cui, X., Zhang, Y., Peng, C., & Wang, Q. (2023) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2023.102280 · Cited by 2
Repositioning of Drug – New Indications for Marketed Drugs
Kong, R., & Wong, S. T. C. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527674381.ch3 · Cited by 2
Drug Repurposing and Multi-Target Therapies
Kumar, A. P., Lukman, S., & Nguyen, M. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20160-x · Cited by 2
Xuan, P., Yang, X., Chen, S., Cui, H., Xu, Z., Jin, Q., & Zhang, T. (2026) · Expert Systems with Applications · doi:10.1016/j.eswa.2026.132150 · Cited by 1
ComTarget: Small-Molecule Target Prediction with Combinatorial Modeling
Li, Y., Shi, Q., Lu, X., Yang, D., Yeerken, D., Jin, H., & Sun, Q. (2026) · Pharmaceuticals · doi:10.3390/ph19050715 · Cited by 1
Using gene sets to identify putative drugs for breast cancer
Hsiao, T., Chen, H.-I. H., Chen, Y., Chen, Y., & Chuang, E. Y.-Y. (2012) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2012.6392616 · Cited by 1
Fatoki, T. H. (2020) · Current Chemical Biology · doi:10.2174/2212796814999200801020729 · Cited by 1
唐, 凯., 叶, 浩., 李, 亦., 杨, 琳., & 曹, 志. (2012) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/csb2012-57-7-534 · Cited by 1
Zheng, Q., Cheng, K., Jin, H., Zhang, W., & Rao, G. (2022) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0054 · Cited by 1
Computational Approaches to Analyze the Strategies of Drug Repositioning*
Da-Fei, X. I. E., Li, P., Li, F., Bo, X., & Wang, S. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2011.00558 · Cited by 1
Scaling and Parallelization of Big Data Analysis on HPC and Cloud Systems
Mikailov, M., Petrick, N., Azarbaijani, Y., Luo, F.-J., Valleru, L., Whitney, S., & Torosyan, Y. (2019) · International Conference on Advances in Computing and Communication Engineering · doi:10.1109/icacce46606.2019.9079987 · Cited by 1
Self-citationShaikh, F., Tai, H. K., Desai, N., & Siu, S. W. I. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12923474.v1 · Cited by 1
Shaikh, F., Tai, H. K., Desai, N., & Siu, S. W. I. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12923474 · Cited by 1
Ye, X.-Y., Ling, Q., & Shao-jun, C. (2017) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902017000216087
Zhang, H., Wang, L., Liu, X., Cao, Y., Zhao, T., Yao, Q., Yue, W., & Wu, L. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12388997.v1
Metadata
- Authors
- Luo, H., Chen, J., Shi, L., Mikailov, M., Zhu, H., Wang, K., He, L., & Yang, L.
- Affiliations
- Shanghai Jiao Tong University (CN)
- United States Food and Drug Administration (US)
- Corresponding author
- He, Lin
- Yang, Lun
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-05-10
- Volume
- 39
- Issue
- suppl_2
- Pages
- W492-W498
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC3125745
- OpenAlex
- W2143251418
- Cited by
- 206
- References
- 54
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 5 · 2023: 12 · 2022: 10 · 2021: 17 · 2020: 18 · 2019: 26 · 2018: 17 · 2017: 13 · 2016: 22 · 2015: 14 · 2014: 15 · 2013: 14 · 2012: 13
- FWCI
- 13.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Keywords
- drug repurposing, adverse drug reactions, off-target interactions, web server, gene expression profiles, anti-infective agents
- MeSH terms
- Rosiglitazone, Anti-Infective Agents, Pharmaceutical Preparations, Humans, Hypoglycemic Agents, Ligands, Proteins, Software, Antipsychotic Agents, Internet, Thiazolidinediones, Drug Repositioning, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review